Fennec Pharmaceuticals Inc (FENC)
9.16
+0.09
(+0.99%)
USD |
NASDAQ |
Apr 25, 16:00
9.17
+0.01
(+0.11%)
After-Hours: 20:00
Fennec Pharmaceuticals Total Assets (Quarterly): 26.86M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 26.86M |
September 30, 2023 | 19.03M |
June 30, 2023 | 19.44M |
March 31, 2023 | 21.82M |
December 31, 2022 | 26.94M |
September 30, 2022 | 30.42M |
June 30, 2022 | 15.57M |
March 31, 2022 | 19.15M |
December 31, 2021 | 22.41M |
September 30, 2021 | 26.01M |
June 30, 2021 | 28.12M |
March 31, 2021 | 27.82M |
December 31, 2020 | 31.42M |
September 30, 2020 | 34.07M |
June 30, 2020 | 39.32M |
March 31, 2020 | 10.37M |
December 31, 2019 | 14.15M |
September 30, 2019 | 15.91M |
June 30, 2019 | 17.83M |
March 31, 2019 | 20.66M |
December 31, 2018 | 22.95M |
September 30, 2018 | 24.94M |
June 30, 2018 | 25.70M |
March 31, 2018 | 26.84M |
December 31, 2017 | 28.40M |
Date | Value |
---|---|
September 30, 2017 | 9.888M |
June 30, 2017 | 10.26M |
March 31, 2017 | 3.288M |
December 31, 2016 | 3.972M |
September 30, 2016 | 4.58M |
June 30, 2016 | 5.104M |
March 31, 2016 | 0.588M |
December 31, 2015 | 1.019M |
September 30, 2015 | 1.45M |
June 30, 2015 | 1.871M |
March 31, 2015 | 1.949M |
December 31, 2014 | 2.372M |
September 30, 2014 | 0.673M |
June 30, 2014 | 1.049M |
March 31, 2014 | 1.395M |
December 31, 2013 | 1.752M |
September 30, 2013 | 0.64M |
June 30, 2013 | 1.03M |
March 31, 2013 | 1.938M |
December 31, 2012 | 2.365M |
September 30, 2012 | 2.93M |
June 30, 2012 | 3.60M |
March 31, 2012 | 4.757M |
December 31, 2011 | 5.351M |
September 30, 2011 | 6.271M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.37M
Minimum
Mar 2020
39.32M
Maximum
Jun 2020
23.51M
Average
22.41M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
Pfizer Inc | 226.50B |
OptiNose Inc | 107.73M |
NovaBay Pharmaceuticals Inc | 9.034M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 38.49M |
Shareholders Equity (Quarterly) | -11.62M |
Debt to Equity Ratio | -2.661 |
Current Ratio | 3.556 |
Net Debt Paydown Yield | -0.41% |